Revvity (RVTY) Cash & Current Investments (2009 - 2026)
Revvity's (RVTY) quarterly Cash & Current Investments came in at $1.0 billion in Q3 2026, up 3.13% on a YoY basis from $991.8 million in Q3 2025, and up 18.9% quarter-over-quarter from $860.3 million in Q2 2026.
Analysis
Revvity (RVTY) Cash & Current Investments (2009 - 2026) Analysis & Trends
Revvity (RVTY) has reported Cash & Current Investments for 18 consecutive years, with $1.0 billion the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Cash & Current Investments rose 3.13% year-over-year to $1.0 billion; the trailing twelve-month figure through Jul 2026 stood at $1.0 billion (up 3.13% YoY), and the FY2025 full-year result was $919.9 million, down 20.93% from the prior year.
- Cash & Current Investments advanced to $1.0 billion in Q3 2026 per RVTY's latest filing, from $860.3 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $2.5 billion in Q2 2023 and bottomed at $345.9 million in Q3 2022.
- Historically, Cash & Current Investments has averaged $1.2 billion across 5 years, with a median of $1.0 billion in 2026.
- The sharpest annual moves came in 2023 and 2025: Cash & Current Investments jumped 498.78% in 2023, then sank 49.25% in 2025.
- Over 5 years, Cash & Current Investments stood at $400.7 million in 2022, then surged by 300.03% to $1.6 billion in 2023, then slipped by 27.43% to $1.2 billion in 2024, then retreated by 20.93% to $919.9 million in 2025, then climbed by 11.21% to $1.0 billion in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $1.0 billion, $860.3 million, and $919.9 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 4.06 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 4.35 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 1.76 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 1.17 Bn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 1.02 Bn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 264.71 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 1.62 Bn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 1.01 Bn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 552.03 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 217.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 1.02 Bn |
| Apr 5, 2026 | 860.32 Mn |
| Dec 28, 2025 | 919.86 Mn |
| Sep 28, 2025 | 931.39 Mn |
| Jun 29, 2025 | 991.85 Mn |
| Mar 30, 2025 | 1.14 Bn |
| Dec 29, 2024 | 1.16 Bn |
| Sep 29, 2024 | 1.23 Bn |
| Jun 30, 2024 | 1.95 Bn |
| Mar 31, 2024 | 1.70 Bn |
| Dec 31, 2023 | 1.60 Bn |
| Oct 1, 2023 | 1.43 Bn |
| Jul 2, 2023 | 2.07 Bn |
| Apr 2, 2023 | 2.46 Bn |
| Jan 1, 2023 | 454.36 Mn |
| Oct 2, 2022 | 400.74 Mn |
| Jul 3, 2022 | 345.86 Mn |
| Apr 3, 2022 | 654.76 Mn |
| Jan 2, 2022 | 603.32 Mn |
| Oct 3, 2021 | 472.37 Mn |